These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9797251)

  • 41. Thiophene containing trisubstituted methanes [TRSMs] as identified lead against Mycobacterium tuberculosis.
    Singh P; Manna SK; Jana AK; Saha T; Mishra P; Bera S; Parai MK; Kumar M SL; Mondal S; Trivedi P; Chaturvedi V; Singh S; Sinha S; Panda G
    Eur J Med Chem; 2015 May; 95():357-68. PubMed ID: 25828928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
    Mor N; Esfandiari A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2035-6. PubMed ID: 9303411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of the Carpobrotus edulis methanol extract on the growth of phagocytosed multidrug-resistant Mycobacterium tuberculosis and methicillin-resistant Staphylococcus aureus.
    Martins M; Ordway D; Kristiansen M; Viveiros M; Leandro C; Molnar J; Amaral L
    Fitoterapia; 2005 Jan; 76(1):96-9. PubMed ID: 15664469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
    Erturan Z; Uzun M
    Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular
    Khalil ZG; Hill TA; De Leon Rodriguez LM; Lohman RJ; Hoang HN; Reiling N; Hillemann D; Brimble MA; Fairlie DP; Blumenthal A; Capon RJ
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial activities of cinnamyl rifamycin derivatives, T-9 and T-11, against Mycobacterium tuberculosis and Mycobacterium avium complex (MAC) with special reference to the activities against intracellular MAC.
    Sato K; Shimizu T; Dimova V; Tomioka H
    Microbiol Immunol; 2006; 50(8):621-3. PubMed ID: 16924146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model.
    Rey-Jurado E; Tudó G; Soy D; González-Martín J
    Int J Antimicrob Agents; 2013 Dec; 42(6):524-30. PubMed ID: 24080479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 51. Design and synthesis of novel carbazole tethered pyrrole derivatives as potent inhibitors of Mycobacterium tuberculosis.
    Surineni G; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2015 Feb; 25(3):485-91. PubMed ID: 25559743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
    Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
    J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Ramos DF; Almeida da Silva PE
    Pharm Biol; 2010 Mar; 48(3):260-3. PubMed ID: 20645810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bis-imidazolinylindoles are active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Mycobacterium tuberculosis.
    Panchal RG; Lane D; Boshoff HI; Butler MM; Moir DT; Bowlin TL; Bavari S
    J Antibiot (Tokyo); 2013 Jan; 66(1):47-9. PubMed ID: 23149517
    [No Abstract]   [Full Text] [Related]  

  • 55. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Whole-cell screening-based identification of inhibitors against the intraphagosomal survival of Mycobacterium tuberculosis.
    Khare G; Kumar P; Tyagi AK
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6372-7. PubMed ID: 24060878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of DNF-3 against drug-resistant Mycobacterium tuberculosis.
    Islam MI; Han CM; Seo H; Kim S; Mahmud HA; Nam KW; Lee BE; Sadu VS; Lee KI; Song HY
    Int J Antimicrob Agents; 2019 Jul; 54(1):69-74. PubMed ID: 30807817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of meropenem against multidrug-resistant Mycobacterium tuberculosis.
    Coban AY; Bilgin K; Tasdelen Fisgin N; Uzun M; Durupinar B
    J Chemother; 2008 Jun; 20(3):395-6. PubMed ID: 18606602
    [No Abstract]   [Full Text] [Related]  

  • 59. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
    Ahmad Z; Sharma S; Khuller GK; Singh P; Faujdar J; Katoch VM
    Int J Antimicrob Agents; 2006 Dec; 28(6):543-4. PubMed ID: 17101262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of new-fangled dispiropyrrolothiazoles as antimycobacterial agents.
    Almansour AI; Ali S; Ali MA; Ismail R; Choon TS; Sellappan V; Elumalai KK; Pandian S
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7418-21. PubMed ID: 23122863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.